![]() Music |
![]() Video |
![]() Movies |
![]() Chart |
![]() Show |
![]() |
Introduction to endpoints in oncology clinical trials (mycsg) View |
![]() |
Lecture Medical Oncology - Endpoints in clinical trials (European Association of Urology) View |
![]() |
Use of Surrogate Endpoints in Oncology (Duke Margolis) View |
![]() |
RECIST 1.0 and 1.1: Overview and Data Challenges in Oncology Clinical Trials Trailer (Kathy Barnett) View |
![]() |
What Makes Oncology Clinical Trials Unique From Others - A Clinical Research Site Perspective (Dan Sfera) View |
![]() |
Phases of Cancer Clinical Trials – An Introduction, with Neal Meropol, MD (Cancer.Net) View |
![]() |
How can MRD negativity be used as an endpoint in clinical trials (HealthTree University for Multiple Myeloma) View |
![]() |
Why Endpoints Matter in Clinical Trials, Daniel Leffler, MD (CeliacDiseaseFoundation) View |
![]() |
RECIST 1.0 and 1.1: Overview and Data Challenges in Oncology Clinical Trials Trailer (Kathy Barnett) View |
![]() |
RECIST 1.0 and 1.1: Overview and Data Challenges in Oncology Clinical Trials Trailer (Kathy Barnett) View |